MRL Shop Information
A communication failure has occured.
Please repeat the process.

|
|
 |
Home > Products > Blazei |

|
 |
 |
 |
 |
| OTHER NAMES USED |
| English |
| - ABM |
|
| Latin |
| - Agaricus blazei |
|
| Japanese |
| - Himematsutake |
|
|
|
Blazei-MRL supports the immune system.*
Index
|
|
Cultivation Process of Blazei MRL
MRL Ltd.´s Agaricus blazei powder contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate.
This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent.

The cultivation system is proprietary, allowing for standardised production of Agaricus blazei. The powder biomass is then sealed in plastic containers.
Picture of the Agaricus blazei
|
|
Certified Organic: USA/EU
The fungal biomass Agaricus blazei that comprises Blazei-MRL is certified 100% Organic in the United States by Quality Assurance International.
In December of 2005, MRL powder gained EU organic certification in accordance with EU Council Regulation (EEC) No. 2092/91 by Quality Assurance International.
|
|
Chemical and Biological Proprieties
Agaricus blazei** Content per gram of biomass (in the absence of Proteolytic Enzymes)
 |
 |
| Cytochrome P-450 |
0.45 nmoles |
| Cytochrome P-450 reductase |
8.90 mU |
| Xylanase |
12.80 U |
| Celulase |
0.38 U |
| Amyloglucosidase |
0.80 U |
| Protein bound polysacharides |
87.6 mg |
| Proteins |
5.16 mg |
| Reducing sugars |
20.38 mg |
| Superoxide dismutase (SOD) |
275.0 U |
| Protease |
11.2 U |
** Agaricus blazei supplied by Mycology Research Laboratories Ltd.
Blazei-MRL –Enzyme activity (U/500 mg Biomass)***
 |
 |
| Superoxide dismutase (SOD) |
143.5 103 U |
| NADPH (Cyt. "P-450" reductase) |
7,500 uM |
| GSH Reductase |
510.0 U |
| Catalase |
996.5 U |
| Laccase |
N/A |
| Tyrosinase |
6849 U |
| Peroxidase |
N/A |
*** Cornelius C. e tal “ Comparative Enzyme Analysis of Polyporus umbellatus, Agaricus blazei, Pleurotus osteratus and Hericium erinaceus” pp 5, Clinical Journal of Mycology, 7;2009 Vol II.
|
|
|
*This statement has not been evaluated by the Food and Drug Adminstration. The product is not intended to diagnose, treat, cure or prevent any disease.
|
|
 |
 |
 |
 |
|